Prism Medico and Pharmacy (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Prism Medico and Pharmacy Limited |
|||
|
Price: ₹25.08 | ||
| 52 Week Low: ₹19.06 52 Week High: ₹39.20 |
|||
| Market Capital: 13.65 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Prism Medico and Pharmacy Share Price Target For 2024
- 1.1.1: Prism Medico and Pharmacy Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Prism Medico and Pharmacy Share Price Target For 2025
- 1.2.1: Prism Medico and Pharmacy Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Prism Medico and Pharmacy Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Prism Medico and Pharmacy Financial Performance
- 3.0.1: Is Prism Medico and Pharmacy A Good Buy For Long Term?
To predict the Prism Medico and Pharmacy's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Prism Medico and Pharmacy Share Price Target For 2024
The line chart displays the monthly closing prices of Prism Medico and Pharmacy with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Prism Medico and Pharmacy shares in 2024, see the table below.
Prism Medico and Pharmacy Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 26.19 (+4.42%) | Price Action: Jul 2023 High |
| 2024 Target 2 | 25.93 (+3.38%) | Price Action: 26 Aug 2024 High |
| 2024 Target 1 | 25.66 (+2.31%) | Price Action: 26 Dec 2024 High |
| Current Price | 25.08 | Prism Medico and Pharmacy's share price as of 26 Dec 2024 |
| Stop Loss 1 | 24.8 (-1.12%) | Price Action: 21 Jul 2023 High |
| Stop Loss 2 | 24.55 (-2.12%) | Price Action: Jan 2010 Low |
| Stop Loss 3 | 24.3 (-3.12%) | Price Action: May 2019 Low |
Short-Term Technical Outlook
Current Technical Position: Prism Medico and Pharmacy is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹25.02 serves as the nearest technical reference point.
Historical Returns: 3-month: -16.37% | 6-month: +3.89% | 1-year: -17.82%
Prism Medico and Pharmacy Share Price Target For 2025
The line chart displays the monthly closing prices of Prism Medico and Pharmacy with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Prism Medico and Pharmacy shares in 2025, see the table below.
Prism Medico and Pharmacy Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 38.51 (+53.54%) | Price Action: Chart |
| 2025 Target 2 | 37.79 (+50.67%) | Price Action: 08 Jan 2024 High |
| 2025 Target 1 | 37.2 (+48.32%) | Price Action: 16 Sep 2024 High |
| Current Price | 25.08 | Prism Medico and Pharmacy's share price as of 26 Dec 2024 |
| Stop Loss 1 | 22.05 (-12.09%) | Price Action: Mar 2024 Low |
| Stop Loss 2 | 21.7 (-13.48%) | Price Action: Aug 2019 Low |
| Stop Loss 3 | 21.45 (-14.48%) | Price Action: Jul 2018 High |
Long-Term Technical Outlook
52-Week Range Analysis: Prism Medico and Pharmacy is currently trading at 29.9% of its 52-week range (₹19.06 - ₹39.2).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -17.82% | 3-year: +123.73% | 5-year: +20.87%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Prism Medico and Pharmacy Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹25.08 | ||
| 2024 | ₹23.88 | -4.78% | ₹24.24 |
| 2025 | ₹25.57 | +7.07% | ₹29.61 |
| 2026 | ₹29.44 | +15.13% | ₹30.19 |
| 2027 | ₹30.01 | +1.93% | ₹30.46 |
| 2028 | ₹24.71 | -17.66% | ₹30.77 |
| 2029 | ₹25.76 | +4.24% | ₹31.35 |
| 2030 | ₹27.56 | +6.98% | ₹31.93 |
| 2031 | ₹31.69 | +14.98% | ₹32.51 |
| 2032 | ₹32.27 | +1.83% | ₹32.75 |
| 2033 | ₹26.54 | -17.75% | ₹33.09 |
| 2034 | ₹27.65 | +4.18% | ₹33.67 |
| 2035 | ₹29.55 | +6.87% | ₹34.24 |
| 2036 | ₹33.95 | +14.89% | ₹34.82 |
| 2037 | ₹34.54 | +1.73% | ₹35.06 |
| 2038 | ₹28.38 | -17.83% | ₹35.40 |
| 2039 | ₹29.96 | +5.56% | ₹35.98 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Prism Medico and Pharmacy Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 13.65 Crore | Market valuation of Prism Medico and Pharmacy's shares. |
| Revenue (TTM) | 1.27 Crore | Total revenue generated by Prism Medico and Pharmacy over the past twelve months. |
| Net Income (TTM) | -7.64 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -8.02% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +10.21% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+8,301.52% | Change in revenue compared to the previous quarter. |
| Total Cash | 9.57 Lakh | Total amount of liquid funds available to Prism Medico and Pharmacy. |
Is Prism Medico and Pharmacy A Good Buy For Long Term?
Based on the provided data, Prism Medico and Pharmacy's financial performance in the last 12 months has been weak, with negative net profit and low profit margin. The stock has also experienced significant losses in recent times, indicating poor investor sentiment. While the company has a small market capitalization, its cash balance is low. Given these factors, Prism Medico and Pharmacy may not be a suitable long-term investment at this time.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
